Pharma 4 Weekly Video Program

Jun 06, 2012
By Pharmaceutical Executive Editors

Pharma Four: Built on the States
July 5, 2012

Links in the Episode:

The Yin and Yang of the Court Decision on HCR
by Tom Norton

Health Reform Declared Constitutional
by Jill Wechsler

GSK Agrees to $3 Billion Settlement with Justice Department
by Amy Ritter

Pharma Four: Nuts to Nutley Edition
June 28, 2012

Links in the Episode:

Is Europe's Health Research Focus Becoming Too Narrow?
by Peter O'Donnell

Nutley leaders: Blindsided by Roche plans to close campus

Pharma Four: Beating Austerity Edition
June 21, 2012

Links in the Episode:

Who's the More Innovative: CROs or Pharma?
by Julian Upton

Supreme Court to Consider Sales Rep Overtime
by Reid Paul

2012 Dealmakers Outlook
by William Looney

360 View of Contract and Budget Negotiations
by Lisa Henderson

Pharma Four: Japan Market Edition
June 14, 2012

Links in the Episode:

Fixing Innovation: Lilly's CEO Says Why, and How
by Ben Comer

Are CT Regulation Deficiencies a Thing of the Past?
by Peter O'Donnell

Obama Was Pushed by Drug Industry, E-Mails Suggest
by Peter Baker

Pharma Four: Risk Based Monitoring Edition
June 7, 2012

Links in the Episode:

FDA User Fee Legislation Nears Passage
by Jill Wechsler

A discussion of R&D spending can be found in the Pharm Exec 50
by Pat Clinton and Jerry Cacciotti

Public-Private Partnerships in Europe
by Amy Ritter

FDA's Risk Based Monitoring Guidance

Low Hanging Fruit in the Fight Against Inefficiency
By Ken Getz

lorem ipsum